The challenges and opportunities of scRNA-seq in COVID-19 research and clinical translation

Abstract The application of single-cell RNA sequencing in COVID-19 research has greatly improved our understanding of COVID-19 pathogenesis and immunological characteristics. In this commentary, we discuss the current challenges, limitations, and perspectives in harnessing the power of single-cell R...

Full description

Bibliographic Details
Main Authors: Wendao Liu, Xiaohua Ye, Zhiqiang An, Zhongming Zhao
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Virology Journal
Subjects:
Online Access:https://doi.org/10.1186/s12985-022-01923-x
_version_ 1811292149266776064
author Wendao Liu
Xiaohua Ye
Zhiqiang An
Zhongming Zhao
author_facet Wendao Liu
Xiaohua Ye
Zhiqiang An
Zhongming Zhao
author_sort Wendao Liu
collection DOAJ
description Abstract The application of single-cell RNA sequencing in COVID-19 research has greatly improved our understanding of COVID-19 pathogenesis and immunological characteristics. In this commentary, we discuss the current challenges, limitations, and perspectives in harnessing the power of single-cell RNA sequencing to accelerate both basic research and therapeutic development for COVID-19 and other emerging infectious diseases.
first_indexed 2024-04-13T04:41:03Z
format Article
id doaj.art-fb605d25e2cc4dcbabfe8610e8788c0a
institution Directory Open Access Journal
issn 1743-422X
language English
last_indexed 2024-04-13T04:41:03Z
publishDate 2022-12-01
publisher BMC
record_format Article
series Virology Journal
spelling doaj.art-fb605d25e2cc4dcbabfe8610e8788c0a2022-12-22T03:02:01ZengBMCVirology Journal1743-422X2022-12-011911410.1186/s12985-022-01923-xThe challenges and opportunities of scRNA-seq in COVID-19 research and clinical translationWendao Liu0Xiaohua Ye1Zhiqiang An2Zhongming Zhao3Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at HoustonTexas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at HoustonMD Anderson Cancer Center UTHealth Graduate School of Biomedical SciencesCenter for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at HoustonAbstract The application of single-cell RNA sequencing in COVID-19 research has greatly improved our understanding of COVID-19 pathogenesis and immunological characteristics. In this commentary, we discuss the current challenges, limitations, and perspectives in harnessing the power of single-cell RNA sequencing to accelerate both basic research and therapeutic development for COVID-19 and other emerging infectious diseases.https://doi.org/10.1186/s12985-022-01923-xCOVID-19SARS-CoV-2Single-cell RNA sequencingCOVID-19 sequelaSingle-cell VDJ sequencing
spellingShingle Wendao Liu
Xiaohua Ye
Zhiqiang An
Zhongming Zhao
The challenges and opportunities of scRNA-seq in COVID-19 research and clinical translation
Virology Journal
COVID-19
SARS-CoV-2
Single-cell RNA sequencing
COVID-19 sequela
Single-cell VDJ sequencing
title The challenges and opportunities of scRNA-seq in COVID-19 research and clinical translation
title_full The challenges and opportunities of scRNA-seq in COVID-19 research and clinical translation
title_fullStr The challenges and opportunities of scRNA-seq in COVID-19 research and clinical translation
title_full_unstemmed The challenges and opportunities of scRNA-seq in COVID-19 research and clinical translation
title_short The challenges and opportunities of scRNA-seq in COVID-19 research and clinical translation
title_sort challenges and opportunities of scrna seq in covid 19 research and clinical translation
topic COVID-19
SARS-CoV-2
Single-cell RNA sequencing
COVID-19 sequela
Single-cell VDJ sequencing
url https://doi.org/10.1186/s12985-022-01923-x
work_keys_str_mv AT wendaoliu thechallengesandopportunitiesofscrnaseqincovid19researchandclinicaltranslation
AT xiaohuaye thechallengesandopportunitiesofscrnaseqincovid19researchandclinicaltranslation
AT zhiqiangan thechallengesandopportunitiesofscrnaseqincovid19researchandclinicaltranslation
AT zhongmingzhao thechallengesandopportunitiesofscrnaseqincovid19researchandclinicaltranslation
AT wendaoliu challengesandopportunitiesofscrnaseqincovid19researchandclinicaltranslation
AT xiaohuaye challengesandopportunitiesofscrnaseqincovid19researchandclinicaltranslation
AT zhiqiangan challengesandopportunitiesofscrnaseqincovid19researchandclinicaltranslation
AT zhongmingzhao challengesandopportunitiesofscrnaseqincovid19researchandclinicaltranslation